Inventor
BEAUMONT TIM
NL29 patents
⚠️ This page may combine multiple inventors who share the name “BEAUMONT TIM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MEDIMMUNE LTD
6 patentsUS10059757B2Aug 28, 2018
RSV-specific binding molecules and means for producing them
MEDIMMUNE LTD8 citations83
US9321831B2Apr 26, 2016
RSV-specific binding molecules and means for producing them
MEDIMMUNE LTD8 citations83
US10035843B2Jul 31, 2018
RSV-specific binding molecule
MEDIMMUNE LTD10 citations82
US9283274B2Mar 15, 2016
RSV specific binding molecule
MEDIMMUNE LTD9 citations82
US10730931B2Aug 4, 2020
RSV-specific binding molecules and means for producing them
MEDIMMUNE LTD3 citations72
US10723786B2Jul 28, 2020
RSV-specific binding molecule
MEDIMMUNE LTD3 citations71
GENENTECH INC
6 patentsUS9458228B2Oct 4, 2016
Gram-positive bacteria specific binding compounds
GENENTECH INC3 citations83
US9399673B2Jul 26, 2016
Gram-positive bacteria specific binding compounds
GENENTECH INC7 citations83
US9266943B2Feb 23, 2016
Gram-positive bacteria specific binding compounds
GENENTECH INC3 citations83
US9090677B2Jul 28, 2015
Gram-positive bacteria specific binding compounds
GENENTECH INC6 citations83
US9927428B2Mar 27, 2018
Gram-positive bacteria specific binding compounds
GENENTECH INC0 citations51
US9688745B2Jun 27, 2017
Gram-positive bacteria specific binding compounds
GENENTECH INC0 citations51
AIMM THERAPEUTICS BV
6 patentsUS10344076B2Jul 9, 2019
Means and methods for producing high affinity antibodies
AIMM THERAPEUTICS BV0 citations50
US10017562B2Jul 10, 2018
RSV G protein specific antibodies
AIMM THERAPEUTICS BV0 citations50
US9718876B2Aug 1, 2017
RSV G protein specific antibodies
AIMM THERAPEUTICS BV0 citations50
US9969795B2May 15, 2018
Means and methods for producing high affinity antibodies
AIMM THERAPEUTICS BV0 citations49
US10556963B2Feb 11, 2020
Means and methods for counteracting myeloproliferative or lymphoproliferative disorders
AIMM THERAPEUTICS BV0 citations45
US10435463B2Oct 8, 2019
Hepatitis C virus specific antibody
AIMM THERAPEUTICS BV0 citations36
BEAUMONT TIM
4 patentsUS8568726B2Oct 29, 2013
RSV specific binding molecule
BEAUMONT TIM62 citations93
US8617556B2Dec 31, 2013
Gram-positive bacteria specific binding compounds
BEAUMONT TIM12 citations91
US9206247B2Dec 8, 2015
Means and methods for producing high affinity antibodies
BEAUMONT TIM7 citations81
US9273118B2Mar 1, 2016
Means and methods for producing high affinity antibodies
BEAUMONT TIM2 citations56
SPITS HERGEN
3 patentsUS8562996B2Oct 22, 2013
RSV-specific binding molecules and means for producing them
SPITS HERGEN33 citations95
US9127251B2Sep 8, 2015
Means and methods for influencing the stability of antibody producing cells
SPITS HERGEN10 citations79
US9718874B2Aug 1, 2017
Influenza A virus specific antibodies
SPITS HERGEN2 citations68
KLING BIOTHERAPEUTICS B V
2 patentsACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM
2 patentsUS10273454B2Apr 30, 2019
Means and methods for influencing the stability of antibody producing cells
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM0 citations47
US9822339B2Nov 21, 2017
Means and methods for influencing the stability of antibody producing cells
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIV VAN AMSTERDAM0 citations47